r3d100011820 CaPSURE Cancer of the Prostate Strategic Urologic Research Endeavor https://urology.ucsf.edu/research/cancer/capsure CaPSURE™ is a longitudinal, observational study of approximately 15,000 men with all stages of biopsy-proven prostate cancer. Patients have enrolled at 43 community urology practices, academic medical centers, and VA hospitals throughout the United States since 1995. CEASAR stands for Comparative Effectiveness Analysis of Surgery and Radiation. The ongoing goal of CEASAR is to help learn more about what prostate cancer treatments work best, for which patients, in whose hands. There are currently about 3,600 men with a prostate cancer diagnosis participating in CEASAR. Three rounds of surveys have been completed, with the first carried out in the spring of 2010. We are currently in the process of conducting our fourth survey with the same group of men in our study. This survey, our Three Year Follow-up, will occur throughout the summer of 2014. https://urology.ucsf.edu/people/peter-r-carroll disciplinary eng 2 Life Sciences 205 Medicine 20514 Hematology, Oncology, Transfusion Medicine 20523 Urology 22 Medicine https://urology.ucsf.edu/about Raw data dataProvider CEASAR Comparative Effectiveness Analysis of Surgery and Radiation. Gleason-Score PSA cancer oncology prostate survey data tumor UCSF Department of Urology University of California San Francisco, Department of Urology USA funding general technical non-profit https://urology.ucsf.edu/ https://urology.ucsf.edu/people/peter-r-carroll Research Guidelines https://urology.ucsf.edu/sites/urology.ucsf.edu/files/uploaded-files/attachments/uroloncdatasets_presentfindings_aug2015_0.pdf restricted other restricted institutional membership other https://ucsf.us.qualtrics.com/jfe/form/SV_2beAaQ5YBmmGxNj closed unknown yes yes CaPSURE is covered by Thomson Reuters Data Citation Index. 2016-02-23 2019-01-09